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Medical therapies and mechanical interventions for the treatment of myocardial infarction (MI) and ischemic heart failure have seen great progress. However, current therapies are only able to slow the progression to heart failure, but cannot stimulate regeneration to recover the loss of functional myocytes. Stem cellbased therapy is a novel modality that may be useful for the treatment of ischemic cardiac injury and heart failure wherein cardiac tissue can be regenerated to improve cardiac function, thus reducing morbidity and mortality for patients. Jeon will review and summarize the current evidence indicating the potential of stem cell therapy, focusing on the clinical trials conducted to date [6] . Lately it has been proven that the satellite cell is capable of initiating muscle regeneration and is capable of self-renewal showing that its role is as a true muscle stem cell. Therefore, stem cell therapy using satellite cells is proposed to be an ideal therapy for muscular dystrophies caused by deficiency of specific muscle protein resulting in muscle degeneration. Especially, Duchenne Muscular Dystrophy (DMD), which is caused by mutations of the dystrophin gene, has been targeted in a number of investigations. In the review by Yang et al., satellite cell characteristics, regulation of cell function, and stem cell therapy for DMD and the progress in recent clinical trials will be discussed [7] .
Recent advances in molecular biology have furnished reprogramming methodologies that give the ability for direct reprogramming of terminally differentiated cells to furnish induced pluripotent stems cells (iPSC), and iPSC are rapidly becoming one of the most important cell sources for various scientific fields and are hoped to be a source for stem cell therapies. Lee will discuss updates concerning production and uses of iPSC [8] .
Advance in the understanding of stem cells (SCs) and the isola- 
